Form 4 for NUS NU SKIN ENTERPRISES, INC.
Accepted 2024-02-14 00:00:00 ET · period of report 2024-02-13 · accession 0001062993-24-003194 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-14 | 2024-02-13 | NUS | Thomas James D | CFO | A - Grant | $0.00 | +2,301 | 34.9K | +7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-13 | A | A | 663 | $0.00 | 33,279 | D | — | — | (F1) On February 22, 2023, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 13, 2024, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. |
| 2 | Common | Class A Common Stock | 2024-02-13 | A | A | 1,638 | $0.00 | 34,917 | D | — | — | (F2) On July 26, 2023, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 13, 2024, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. |